This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: AdverseEvent
Resource AdverseEvent "clinical-research-ae-example-medwatch-patient-report"
Profile: Adverse Event Clinical Research
Criteria reviewed in determining serious adverse event
url
criterionPresent
value: true
url
criterionCode
value: Required Intervention to Prevent Permanent Impairment/damage (NCI Thesaurus#C201939)
Criteria reviewed in determining serious adverse event
url
criterionCode
value: Results In Persistent Or Significant Disability (NCI Thesaurus#C11338)
url
criterionPresent
value: false
Criteria reviewed in determining serious adverse event
url
criterionCode
value: Requires Inpatient Hospitalization (NCI Thesaurus#C83052)
url
criterionPresent
value: false
Criteria reviewed in determining serious adverse event
url
criterionCode
value: Death Related to Adverse Event (NCI Thesaurus#C48275)
url
criterionPresent
value: false
Criteria reviewed in determining serious adverse event
url
criterionCode
value: Is Life Threatening (NCI Thesaurus#C84266)
url
criterionPresent
value: false
Criteria reviewed in determining serious adverse event
url
criterionCode
value: Congenital Anomaly or Birth Defect (NCI Thesaurus#C83117)
url
criterionPresent
value: false
Criteria reviewed in determining serious adverse event
url
criterionCode
value: Other Medically Important Condition (NCI Thesaurus#C82521)
url
criterionPresent
value: false
status: completed
actuality: actual
code: Serious reportable event associated with product or device (SNOMED CT#370901008)
subject: Patient/JanetPatient: Janet " CLINICAL TRIAL PATIENT"
detected: 2023-04-10
resultingEffect: Condition/janetReported-condition
seriousness: Serious (AdverseEventSeriousness#serious)
outcome: Recovered/Resolved (NCI Thesaurus#C49498)
recorder: Patient/JanetPatient " CLINICAL TRIAL PATIENT"
study: ResearchStudy/BreastCancerTrial
suspectEntity
instance: Medication/bresentrik
Causalities
EntityRelatedness Author Possibly Related (NCI Thesaurus#C53258) Patient/JanetPatient: Janet " CLINICAL TRIAL PATIENT"
suspectEntity
instance: ResearchStudy/BreastCancerTrial
Causalities
EntityRelatedness Author Possibly Related (NCI Thesaurus#C53258) Patient/JanetPatient: Janet " CLINICAL TRIAL PATIENT"
supportingInfo
item: MedicationAdministration/medicationAdministration-for-bresentrik
supportingInfo
item: Observation/weight-janet
supportingInfo
supportingInfo
supportingInfo
supportingInfo
note: A 64-year-old woman (Janet) is participating in a breast cancer clinical trial and taking an investigational drug. As part of her participation in the study, she was instructed to use a patient reported outcomes (ePRO) application to report an adverse event that resulted in any of the following: hospitalization, required help to prevent permanent harm, disability or health problem, birth defect, life-threatening, death, other serious/important medical incident (this list identifies the event as being serious events). The application is designed to capture data elements found on the 3500A Form. The Clinical Investigator (CI) receives a notification that Janet has an adverse event and reviews the event in Janet’s EHR system. The adverse event form is pre-populated from EHR data for the clinical investigator. The CI assesses causality for Janet’s adverse event and submits the serious adverse event to the sponsor. The sponsor reviews the received adverse event and performs its own causality assessment. Since this event is a Suspected Unexpected Serious Adverse Reaction (SUSAR) within FDA’s regulation. If the Suspected Unexpected Serious Adverse Reaction (SUSAR) was life threatening or death, it is submitted within 7 calendar days. Any other types of seriousness are submitted within 15 calendar days. (By Patient/JanetPatient @2023-04-12)